Browse products

Related products

more on pharma »
more on Central and Eastern Europe »

Central Europe Pharma Online

1 year subscription to internet service providing market news and analytical articles
Central Europe Pharma Online 1 year subscription to internet service providing market news and analytical articles

Subscription: 1 year

Delivery: online access


Our clients say... 
“We use PMR's services due to their analysts' extensive experience in market analysis, their high quality and level of engagement in the market research carried out for us. We consider PMR a competent and professional company and recommend them as a reliable partner in the area of economic information and market analysis.” Senior Trade and Investment Adviser, British Embassy in Warsaw
“PMR's analysts understand our needs well and the standard of their service has always fully met our expectations. We are looking forward to cooperating with PMR in the future as well. ” Senior Trade and Investment Adviser, British Embassy in Warsaw
“The information provided is very up-to-date and keeps us in the loop. Switching from pdf to online access proved to deliver even better results. We would always recommend PMR as a one-stop shop for all you need to know before making any decision. Thanks for all your efforts. ” Development Manager, GVA Grimley
“It's a great pleasure to cooperate with PMR because of its analysts' wealth of experience in understanding the local market. We consider PMR a competent and professional company which helps us conduct our business. I would also like to state that PMR's team is always ready to respond to emerging customer needs. We can recommend it as a reliable partner.” Business Analyst, Hilti Distribution, Russia
“I have been using PMR news update services for a few months and I appreciate their professionalism, kindliness of the staff, punctuality and quality of materials. I would strongly recommend the news update services as it is an economical way to save in-house company resources.” Senior Analyst, Beragua Capital Advisory
“We consider PMR a competent and professional company. PMR analysts understand our needs clearly and their services have fully met our expectations. I strongly recommend the company as a reliable partner in providing economic information and market analysis.” General Manager, Sanofi-Synthelabo
“I am very satisfied with the service that PMR provides us. Our business needs up-to-date information as we would like to catch all the opportunities in our fast-growing markets. I receive all the important news about CEE and Russia from one source and gain insight from PMR markets analysis. I can recommend PMR as a partner to all companies who wish to make business on a professional level in this region.” Development Director, Baltika Group
“Sanofi-Aventis group regularly order PMR's reports and newsletters concerning the Polish pharmaceutical market. We use PMR's services because of the wealth of experience of its analysts in undertaking market analysis and a high level of quality and involvement in the field of market research. ” General Manager, Sanofi-Synthelabo
“As a London-based company, with operations abroad, we looked for the best-in-class Market Intelligence supplier. PMR brought us quality reports that improved our CEE market knowledge and understanding.” Development Manager, GVA Grimley
“I really appreciate regularly receiving the most significant market information of our principal marketing area in a consolidated format. The PMR services include not only an accurate level of detail, but also have central instruments such as a subject index and an abstract for the conclusion, allowing a fast orientation. ” Chief Marketing Officer, Eisberg Group
Serving as an interactive online resource across a number of business levels within the pharmaceutical sector in Central Europe, Central Europe Pharma Online provides readers with market intelligence, commentaries, analysis and the latest news on Bulgaria, Czech Republic, Hungary, Poland, Slovakia, Romania, Russia and the CIS countries.
 
With archives dating from 2004 and daily news updates, the service delivers up to 70 daily news stories, bi-weekly analytical articles and monthly commentaries. Readers benefit from easy access to content prepared by PMR editors and market analysts, as part of the annual subscription licence.

This service is also available in pdf format newsletter - Central Europe Pharma News.

Compare PDF to online access.

Annual subscribers to Central Europe Pharma Online benefit from:

  • Daily news: profiled by country and covering market, R&D and medical and company news
  • Bi-weekly analytical articles: presenting analysis, insight and forecasts by PMR market analysts
  • Monthly commentaries: analysing major developments in the pharmaceutical sector
  • Interviews: featuring top industry executives and providing company opinion
  • Country surveys: in-depth analysis of dedicated country pharmaceutical markets containing PMR research and analysis
  • Customised electronic newsletters: delivered to your desktop on a weekly basis
  • Archive: unlimited instant access anywhere and at any time to the archive of Central Europe Pharma Online
  • Easy use and access: user-friendly tools, features and applications deliver the information directly to your desktop

Keep abreast of the latest industry news and developments

Central Europe Pharma Online delivers news by context:
  • Market news – reports on the size of the pharmaceutical sector in the specific CEE country and the region and its market segments, regulatory and legislative changes affecting the market, drug and reimbursement policies and healthcare funding.
  • R&D and Medical news – covers industry developments and innovations, planned investments and development of the private healthcare market.
  • Company news – profiles pharmaceutical and healthcare companies operating in the market, mergers and acquisitions, new drug launches and company development and expansion strategies.

New! Database of mergers and acquisitions

The convenient online tool offers information about mergers and acquisitions on the pharmaceutical and medical market within Central and Eastern Europe and Poland.
The information contained in the database can be easily filtered according to the following variables: country (both the merging and the acquiring), date of completion, status of the transaction (incomplete – completed), value of the transaction, sector.

Learn from PMR research and analysis for your next strategic move

  • Expert commentaries delivered by PMR market analysts, economists or external industry practitioners share their knowledge and provide opinion on the complex issues affecting the sector - from major market developments (regulatory and legal changes, pricing or reimbursement) to major events (mergers and acquisitions, partnership agreements).
  • Analytical articles present analysis, insight and forecasts written by PMR editors, pharma analysts and correspondents from specific country markets, or based on PMR market reports containing proprietary research or survey findings on a given topic.
  • Interviews with top executives of pharmaceutical companies or industry experts provide first hand opinion on company activities and developments and particular field of the pharma/healthcare market.

Access instantly, search quickly and use easily

Whether on the move or at work, subscribers can stay connected to Central Europe Pharma Online by simply logging in and accessing the information they need direct to their desktops.
  • A multi-criteria search facility enables quick search by country, specific key word or topic, news items, specific features or market reports and provides instant access to an extensive archive of previously published information on the market across the region.
  • Easy customisation allows users to store recently read articles, receive customised newsletters directly to their inbox and contribute feedback and comments.
  • Directly accessible, subscribers can collate, print and export articles and materials in Word or PDF format for handy use at client presentations, company meetings and strategy group discussions. Indicator tables and graphs enlarged with a click can be printed as reference materials.

Industry decision makers trust PMR Central Europe Pharma Online

Central Europe Pharma Online is a credible and trusted source of information and market analysis for keeping up to date with the latest market trends and developments.
Senior pharmaceutical and healthcare executives use the service to monitor market trends and developments, access market data, consult historical archives and keep abreast of market expansion and development plans.
Investment and private equity funds, research firms, consultancies, government and trade organisations rely on PMR information and research for market knowledge and future investment opportunities. 

PMR Online – video presentation:

Learn more about PMR Online news services from the video presentation.
To order free trial fill in the form below.

Request more info/demo access

To receive more information on this online service, please sign up.

*required

*Would you like a FREE
interactive screenshare?
*Email:
To make sure you receive the requested information, add info@pmrcorporate.com to your company trusted emails. Contact your IT department for details.
*Your company core business:

Privacy Policy

Central Europe Pharma Online
1 year subscription to internet service providing market news and analytical articles

Choose your version of this product:

Select
language: 		Select
licence: 		     Price: 1450 €
Language / Licence Single 5 Users Corporate Global
English1450€1950€2900€3800€

Compare licences
  • "Single user licence" entitles the client to use the product (in its entirety or in part, and in the case of an online product also to use the access data to this product) only and exclusively in the following fields of exploitation:
    • - for the product preservation: saving the product in the memory of one computer belonging to the client;
    • - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for the individual use of one person only, who is indicated by the client during purchasing process.

      Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
  • "5-user licence" entitles the client to use the product (in its entirety or in part, and in the case of an online product also to use the access data to this product) only and exclusively in the following fields of exploitation:
    • - for the product preservation: saving the product in the memory of 2 to 5 computers belonging to the organisation indicated by the client while purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
    • - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for 2 to 5 people who work for the organisation indicated by the client during purchasing process, and who are in the same country as the organisation indicated during purchasing process.

      Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
  • "Corporate licence" entitles the client to use the product (in its entirety or in part, and in the case of an online product also to use the access data to this product) only and exclusively in the following fields of exploitation:
    • - for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers must be located in the same country as the organisation indicated during purchasing process;
    • - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in the same country as the organisation indicated during purchasing process.

      Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
  • "Global licence" entitles the client to use the product (in its entirety or in part, and in the case of an online product also to use the access data to this product) only and exclusively in the following fields of exploitation:
    • - for the product preservation: saving the product in the memory of an unlimited number of computers belonging to the organisation indicated by the client during purchasing process; these computers can be located in or outside of the country of the organisation indicated during purchasing process;
    • - for multiplying and making the product available: multiplication of the product by production of its copies either by printing or by digitalisation (e.g. on a disc, CD-ROM, DVD, magnetic tape, magneto-optic carrier, print and electronic devices, including electronic paper) for an unlimited number of people who work for the organisation indicated by the client during purchasing process, who are in or outside of the country of the organisation indicated during purchasing process.

      Any other preservation, multiplication, copying and dissemination etc. which is beyond the scope of this licence is strictly forbidden.
    PMR is a member of SIIA's Corporate Content Anti-Piracy Program. Breaking the conditions of our licences will result in a report being sent to SIIA to initiate a piracy investigation and major fees may be imposed by the SIIA as a result. Additionally, for newsletters and online services, it will result in suspension of the subscription with no money refund.